Email Updates

Place quotation marks around exact phrases (e.g. "new york"). Note: Trial names have a space before the number (e.g. HVTN 100).

You are here

Home

Trial Search

Trial Name Prevention Option Phase Start Date Sponsors Countries Population Candidate(s) Status
Cabotegravir implant (Preclinical) Microbicides, PrEP Pre-clinical NIAID United States of America Men Cabotegravir (GSK 744) Completed
IPM 056 / CCN019B Multipurpose Prevention Technologies, PrEP I/II June 2022 IPM, NICHD, NIH United States of America Women Dapivirine-Levonorgestrel ring Ongoing
EBONI PrEP IV August 2022 GSK Clinical Trials ViiV Healthcare Transgender women, Women Cabotegravir (GSK 744) Ongoing
HVTN 141/ HPTN 105 PrEP Open Label March 2023 Men, Women
Purpose 4/ HPTN 103 PrEP Open Label Injecting drug users Lenacapavir Planned
PURPOSE 3/ HPTN 102 PrEP Open Label Women Lenacapavir , TDF/FTC (Truvada) Planned
HPTN 074 PrEP, Treatment Open Label, III February 2015 HPTN, NIDA, NIAID Indonesia, Ukraine, Thailand HIV positive, Injecting drug users Completed
HPTN 091 PrEP Open Label March 2021 HPTN, Gilead United States of America, Brazil Men TAF/FTC (Descovy), TDF/FTC (Truvada)
HPTN 096 General, PrEP, Treatment Open Label, Other April 2022 HPTN; DIAID, NAID HIV positive, MSM Ongoing
HPTN 094/ INTEGRA General, PrEP, Treatment Demo Project, Open Label June 2021 NIAID (DAIDS ID: 38715) United States of America HIV positive, Injecting drug users, Men, Women Ongoing
PURPOSE 2 PrEP III June 2021 Gilead Sciences United States of America Men, MSM, Transgender men, Transgender women Lenacapavir , F/TDF Ongoing
Impower 024 PrEP III March 2021 Merck Sharp & Dohme Corp. Men, MSM, Transgender women Islatravir (MK-8591) Stopped Early
Impower 022 PrEP III February 2021 Merck Sharp & Dohme Corp. United States of America, South Africa Women Islatravir (MK-8591), TDF/FTC (Truvada) Stopped Early
SSPN formulations of novel emtricitabine PrEP Pre-clinical emtricitabine
Transdermal Delivery System for Tenofovir Alafenamide PrEP Pre-clinical Eastern Virginia Medical School, CONRAD, Corporation of Mercer University, USAID/PEPFAR F/TAF Stopped Early
CAPRISA 018 PrEP I January 2017 Centre for the Aids Programme of Research in South Africa; Stichting Amsterdam Institute for Global Health and Development; Université Jean Monnet, Saint-Etienne Women tenofovir Ongoing
MK-8591-016 PrEP II September 2019 United States of America, Malawi, South Africa, Israel Men Islatravir (MK-8591) Stopped Early
CONRAD A15-140 Microbicides, PrEP I April 2016 United States of America Women TFV ring, TDF/FTC (Truvada) Completed
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian transgender women (PrEParadas) PrEP Demo Project July 2018 Brazilian Ministry of Health Brazil Ongoing
MTN-041/ MAMMA Microbicides, PrEP Other May 2018 NIAID (DAIDS-ES: 38161) Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing

Pages

CSVDoc